PROTARA THERAPEUTIC INC (TARA) Stock Income Statement
NASDAQ:TARA - Nasdaq - US74365U1079 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 51.00M | 49.00M | 44.00M | 37.54M | 47.49M | |||
| Research and Development | 33.10M | N/A | 24.79M | 16.67M | 21.09M | |||
| Selling, General, and Administrative Expenses | 18.32M | 17.00M | 18.00M | 20.63M | 26.40M | |||
| Operating Income | -51.00M | -49.00M | -44.00M | -37.54M | -47.49M | |||
| Interest Income/Expense | 5.14M | N/A | 3.19M | 1.11M | 240.00K | |||
| Other Income/Expense | N/A | 4.00M | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | -29.52M | N/A | |||
| Income Before Taxes | -45.51M | -45.00M | -40.00M | -65.95M | -47.25M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -45.51M | -45.00M | -40.00M | -65.95M | -47.25M | |||
| EBITDA | -50.67M | -48.67M | -43.66M | -37.29M | -47.37M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.71 | -2.14 | -3.63 | -5.86 | -4.21 | |||
| Non GAAP EPS | -1.73 | -2.41 | -3.57 | -3.99 | -4.21 | |||
| Statistics | ||||||||
All data in USD